What we found on the web about RECEPTORS
Receptor (biochemistry) - Wikipedia, the free encyclopedia
In biochemistry, a receptor is a protein molecule, embedded in either the plasma membrane or the cytoplasm of a cell, to which a mobile signaling molecule may attach.
Sensory receptor - Wikipedia, the free encyclopedia
In a sensory system, a sensory receptor is a sensory nerve ending [1] that recognizes a stimulus in the internal or external environment of an organism.
Receptors - definition of Receptors in the Medical dictionary - by the ...
receptor /re·cep·tor/ (-ter) 1. a molecule on the surface or within a cell that recognizes and binds with specific molecules, producing a specific effect in the cell; e.g., the ...
receptor - definition of receptor by the Free Online Dictionary ...
re·cep·tor (r-s p t r) n. 1. Physiology A specialized cell or group of nerve endings that responds to sensory stimuli. 2. Biochemistry A molecular structure or site on the ...
cPanel®
Great Success ! Apache is working on your cPanel ® and WHM™ Server. If you can see this page, then the people who manage this server have installed cPanel and WebHost Manager ...
Histamine and its receptors
Histamine H2 receptors. H2-receptor antagonists. The search for other ... Histamine H4 receptors. Mutagenesis studies. Constitutive activity ... receptors ...
Molecular Biology of Serotonin Receptors
The number of different receptors identified by molecular cloning has provided ... Many receptors have been cloned, and the data conclusively confirm the ...
How to Restore Opiate Receptors | eHow.com
How to article - how to restore opiate receptors. Drug addiction from opiate-based substances is one of the hardest addictions to overcome. Opiate receptors in the...
Receptor Logic :: Immunology On Target
Targeting a new class of disease specific biomarkers, our products provide next generation treatments for cancer, infectious disease, and chronic disease.
3. Neurotransmitter Postsynaptic Receptors
A. Ionotropic (ligand-gated) receptors ... 7. Positive neuromodulation of GABAa receptors: tranquilizers ... B. Metabotropic (G-protein coupled) receptors ...
{delta} Subunit Susceptibility Variants E177A and R220H ...
GABAA receptors are ligand-gated chloride channels that mediate the majority of ... GABAA receptors play a critical role in several animal models of seizures (Sperk ...
Prostanoid Receptors: Structures, Properties, and Functions ...
... OF PROSTANOID RECEPTORS AND THEIR ... and Isoform Generation of Prostanoid Receptors ... MOUSE STUDIES OF PROSTANOID RECEPTORS. A. Central Nervous System ...
Opioid Receptors
Opioid Receptors. Alistair Corbett, Sandy McKnight and Graeme Henderson. Dr Alistair Corbett is Lecturer in the School of Biological and Biomedical Sciences, Glasgow ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about RECEPTORS

In biochemistry, a receptor is a protein molecule, embedded in either the plasma membrane or the cytoplasm of a cell, to which a mobile signaling molecule may attach. A molecule which binds to a receptor is called a ligand, and may be a peptide or other small molecule, such as a neurotransmitter, a hormone, a pharmaceutical drug, or a toxin. When such binding occurs, the receptor undergoes a conformational change, which ordinarily initiates a cellular response. However, some ligands (e.g. antagonists) merely block receptors without inducing any response. Ligand-induced changes in receptors result in cellular changes which constitute the biological activity of the ligands.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention RECEPTORS
Æterna Zentaris gets positive data from phase-2 study of targeted cytotoxic peptide conjugate, AEZS-108
PharmaBiz
Æterna Zentaris Inc, a global biopharmaceutical company focused on endocrine therapy and oncology, announced positive efficacy data from a phase-2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients ...
'Comfort food' relieves stress: Australian study
YAHOO!
The deficit in stress hormone receptors in part of the brain that we saw in the stressed animals was reversed by the diet," she said. But Morris warned against hasty conclusions, saying more work needed to be done on the benefit of other fa...
Micromet Enters Into Agreement With Lonza for the Manufacture of Blinatumomab
dBusinessNews.com
BETHESDA, Md -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that it has entered into an agreement for the process de...
Gut study may aid more effective probiotic selection
Nutraingredients.com
UK researchers based in the Institute of Food Research and the University of East Anglia have obtained the first crystal structure of a mucus-binding protein (MUB) from a strain of Lactobacillus reuteri , a lactic acid bacterium naturally f...
Robert J. Wenthold, 61
Washington Post
Wenthold cloned a member of the family of receptors for glutamate, a chemical that stimulates neurons in the brain and is important for hearing, learning and memory. The next year, he developed the first antibodies to these receptors, which...
Merck, Idera Pharmaceuticals extend their vaccine research collaboration
News-Medical-Net
Idera Pharmaceuticals, Inc. today announced that Merck & Co., Inc., through an affiliate, has extended its research collaboration with Idera for a fourth year. In December 2006, the companies entered into an exclusive license and research c...
ChemoCentryx Reports Positive PROTECT-1 Study Results For Traficet-EN(TM) At The GASTRO 2009 UEGW/WCOG Conference
Medical News Today
ChemoCentryx, Inc., announced that Phase II/III clinical data from the Company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn...